| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |